Seeking Alpha

Schering-Plough Corp. (SGP)

()

Comments on SGP

  • The Real Price of Big Pharma's Huge Fines [View article]
    How about removing the "off-label" promoted drugs off Medicare/Medicaid formularies? This is the ultimate wake-up call!
    Comment by Buckeye Jim
    Nov 10 23:54 pm |
    Rating: 0 0
  • The Real Price of Big Pharma's Huge Fines [View article]
    How about 5 years or fine equal to total compensation received for the past 5 years? After the first couple of convictions, everyone... More »
    Comment by Suzit
    Nov 10 13:10 pm |
    Rating: 0 0
  • The Real Price of Big Pharma's Huge Fines [View article]
    DDMAC warning letters from FDA are always addressed to the CEO, but merely admonish the company to take corrective actions. If those... More »
    Comment by pharmaveteran
    Nov 10 10:47 am |
    Rating: 0 0
  • The Real Price of Big Pharma's Huge Fines [View article]
    So true Mr. Lowe, so true. While criminal penalties would definitely have an impact, most people would think the penalty... More »
    Comment by policy_redux
    Nov 10 09:39 am |
    Rating: 0 0
  • The Real Price of Big Pharma's Huge Fines [View article]
    The real solution is to put some corporate officers in jail--when monetary penalties are meaningless we need to look at other forms of... More »
    Comment by User 450353
    Nov 10 08:53 am |
    Rating: +2 0
  • The Real Price of Big Pharma's Huge Fines [View article]
    How true!!!! The old saying in the industry 20 years ago was that Pfizer never let science get in the way of marketing. Afterall, if... More »
    Comment by idlut
    Nov 10 08:01 am |
    Rating: 0 0
  • Johnson & Johnson: The Elephant in the Merck-Schering Living Room [View article]
    This is a big issue that seems to garner little attention at the moment for JNJ. It is a heads i win, tails i don't lose anything... More »
    Comment by Frank Waddell
    Nov 5 10:41 am |
    Rating: +2 0
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    How do explain the fact that US Pharma companies spend 2 - 3 times in BME (business development, advertising, marketing and lobbying)... More »
    Comment by E Nuff Sed
    Nov 2 23:03 pm |
    Rating: +1 0
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    Listen Grandad. Pharma research is exactly like defense. In the past, the U.S. has defended the rest of the world because the other... More »
    Nov 1 22:19 pm |
    Rating: 0 0
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    c smith: if you have that private pay data readily available for the other companies, that would be good data to share
    Comment by Richard Shaw
    Nov 1 11:03 am |
    Rating: 0 0
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    c smith: nice point
    Comment by Richard Shaw
    Nov 1 10:40 am |
    Rating: 0 0
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    A better measure of sensitivity to ObamaCare is percentage of revenue which is "private pay"; i.e.; that which is not publicly funded... More »
    Comment by c smith
    Oct 31 20:37 pm |
    Rating: +1 0
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    Herbal or alternative or fringe etc. medications are not the issue. Hard science pharma (or a reasonable facsimile in view of the... More »
    Comment by searcher
    Oct 31 14:58 pm |
    Rating: +1 0
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    I suspect the concern raised by the author is overblown. Other than adding more lives to be insured and saddling the taxpayer with more... More »
    Comment by skwestorange
    Oct 31 14:39 pm |
    Rating: +1 -1
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    The FDA just sent a threatening letter to Dr. Weil for advocating use of an herbal preparation that many use and have reported benefit... More »
    Comment by Jade Queen
    Oct 31 12:18 pm |
    Rating: 0 -2